Material-dependent oxygen transport governs ischemia-reperfusion injury and drug response in a kidney microphysiological system

Probably not a substantial claim: may not pass S3 (load-bearing).

Other studies have demonstrated that HIF-1α levels decrease over time after I/R.

“other studies have also demonstrated that HIF-1α levels decrease over time after I/R (Conde et al., 2012).”

• cites Conde et al., 2012 sourceDisputed

  The Results section, “HIF-1α is induced after ischemia and during reperfusion in vivo” (page unavailable), reports HIF-1α expression during reperfusion at days 3, 5, and 7, rather than a decrease over time after I/R. The Discussion also describes significant HIF-1α protein accumulation during reperfusion. (LLM, conf=0.86)

  Checked by a reasoning model — may be wrong.

  Experimental — accuracy not yet measured

May combine two claims.

Rapid reperfusion during the reperfusion phase leads to oxidative stress, mitochondrial dysfunction, and cell death, thereby impairing renal function.

“rapid reperfusion during the reperfusion phase leads to oxidative stress, mitochondrial dysfunction, and cell death, thereby impairing renal function”

• cites Lasorsa et al., 2024 sourceSupported
• cites Pefanis et al., 2019 sourceNot checked — no full text of the source

May combine two claims.

Upon reperfusion, abrupt reoxygenation triggers a burst of mitochondrial superoxide production and a transient increase in tissue ROS.

“Upon reperfusion, abrupt reoxygenation triggers a burst of mitochondrial superoxide production and a transient increase in tissue ROS”

• cites Pefanis et al., 2019 sourceNot checked — no full text of the source
• cites Huang et al., 2024 sourceNot checked — no full text of the source
• cites Lasorsa et al., 2024 sourcePartly supported

  Section 2 (Pathophysiology of IRI; page not specified) says restored oxygen supply causes harmful ROS production and that ROS production is higher during reperfusion. Section 3 (Metabolic Reprogramming during IRI; page not specified) identifies mitochondria as a ROS source and superoxide as a mitochondrial ROS. Neither passage establishes a burst specifically of mitochondrial superoxide upon reperfusion or says the tissue ROS increase is transient. (LLM, conf=0.87)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

In the human kidney, cortical O2 partial pressure is approximately 50 mmHg under physiological conditions.

“in the human kidney, the cortical O2 partial pressure is approximately 50 mmHg under physiological conditions”

• cites Evans et al., 2008 sourceNot checked — no full text of the source
• cites Hansell et al., 2013 sourceCould not verify

  The Introduction says cortical PO2 is higher than medullary PO2, but gives no normal cortical value. A search of our copy for 50 mmHg and for cortical oxygen tension in healthy humans found no passage establishing approximately 50 mmHg in the human kidney under physiological conditions. (LLM, conf=0.73)

  Experimental — accuracy not yet measured

Classified as probably not a substantial claim.

In the human kidney outer medulla, O2 partial pressure falls to approximately 5-25 mmHg.

“falls to ∼5–25 mmHg in the outer medulla”

• cites Evans et al., 2008 sourceNot checked — no full text of the source
• cites Hansell et al., 2013 sourcePartly supported

  The Introduction states that oxygen partial pressure is lower in the medulla than in the cortex and describes a gradient along medullary structures. It does not give a 5–25 mmHg range for the human outer medulla; the human finding discussed in the hypertension section is a relative difference, not an absolute value. (LLM, conf=0.84)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

During ischemia, tissue PO2 can fall below approximately 5 mmHg.

“during ischemia, tissue PO2 can fall below ∼5 mmHg”

• cites Evans et al., 2008 sourceNot checked — no full text of the source
• cites Hansell et al., 2013 sourceCould not verify

  The Introduction discusses low renal tissue PO2 and says acute hypotension can paradoxically increase medullary PO2. The hypertension section reports PO2 as low as 12 mmHg in hypertensive rats. Searches for ischemia and 5 mmHg found no passage stating that tissue PO2 falls below approximately 5 mmHg during ischemia. (LLM, conf=0.73)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

RPTEC/TERT1 is well-suited for experiments involving inserts or MPS and is widely used in our laboratory for studies that model the kidney.

“Furthermore, it is well-suited for experiments involving inserts or MPS and is widely used in our laboratory for studies that model the kidney (Nihei et al., 2025).”

• cites Nihei et al., 2025 sourcePartly supported

  The Introduction and Results (section 3.2) describe kidney-model experiments using hRPTECs on a chip and a static Transwell insert. But Materials and Methods (section 2.2) identifies those cells as primary hRPTECs, not RPTEC/TERT1; the paper also does not establish that RPTEC/TERT1 is widely used in the citing authors’ laboratory. Page numbers are unavailable in our copy. (LLM, conf=0.87)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

Several on-chip systems have demonstrated that cellular injury can be induced under hypoxic and hyponutritional conditions, exacerbated by reperfusion, and attenuated by ischemic protective agents.

“several on-chip systems have demonstrated that cellular injury can be induced under hypoxic and hyponutritional conditions, exacerbated by reperfusion, and attenuated by ischemic protective agents”

• cites Vormann et al., 2022 sourceSupported
• cites Chethikkattuveli Salih et al., 2022 sourceNot checked — no full text of the source
• cites Tool et al., 2024 sourceNot checked — no full text of the source

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

KIM-1 is a type-I membrane protein expressed by injured proximal-tubule cells, is induced after sublethal or lethal tubular injury, and is widely used as an early marker of acute kidney injury.

“KIM-1, a type-I membrane protein expressed by injured proximal-tubule cells, is induced after sublethal or lethal tubular injury and is widely used as an early marker of acute kidney injury (Tanase et al., 2019).”

• cites Tanase et al., 2019 sourcePartly supported

  Section 2.1 describes KIM-1 as a proximal-tubule apical transmembrane protein found in proximal-tubule cells after injury, and sections 2.1 and 5 discuss its use as an early AKI biomarker. The copy does not specify that it is type-I or that it is induced after both sublethal and lethal injury. It also calls for further validation of its use in early diagnosis, so “widely used as an early marker” overstates the clinical-use claim. (LLM, conf=0.85)

  Experimental — accuracy not yet measured

Classified as probably not a substantial claim. May combine two claims.

CDDO is a synthesized triterpenoid that potently activates Nrf2, promotes its nuclear translocation, and induces expression of downstream antioxidant proteins such as NQO1 and HO-1.

“CDDO is a synthesized triterpenoid that potently activates Nuclear factor erythroid 2–related factor 2 (Nrf2), promotes its nuclear translocation (Kurosaki et al., 2022), and induces the expression of downstream antioxidant proteins such as NAD(P)H quinone dehydrogenase 1 (NQO1) and heme oxygenase 1 (HO-1) (Liby et al., 2005).”

• cites Kurosaki et al., 2022 sourcePartly supported

  The Introduction calls CDDO-Me (bardoxolone methyl) a semi-synthetic triterpenoid and potent Nrf2-pathway activator; the Discussion says Nrf2 translocates to the nucleus upon activation by CDDO-Me. The citing sentence instead says CDDO, which the paper does not equate with CDDO-Me. The NQO1 and HO-1 clause is attached to a different citation, so it is not judged against Kurosaki et al. No page numbers are available in our copy. (LLM, conf=0.88)

  Experimental — accuracy not yet measured
• cites Liby et al., 2005 sourceSupported

Classified as probably not a substantial claim. May combine two claims.

KIM-1 is a gene expressed in the proximal tubule that is induced by cellular injury or exposure to toxic substances.

“KIM-1 is a gene expressed in the proximal tubule that is induced by cellular injury or exposure to toxic substances (Tanase et al., 2019).”

• cites Tanase et al., 2019 sourcePartly supported

  Section 2.1, “What Is KIM-1?” (page unavailable), describes KIM-1 as a proximal-tubule transmembrane protein whose levels are low normally and rise after injury, including toxic renal injury. It also says KIM-1 gene expression reflects ongoing damage. The source supports injury-associated expression but identifies KIM-1 itself as a protein, not a gene. (LLM, conf=0.86)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

HIF-1α induction during reperfusion plays a role in preventing inappropriate repair following renal I/R, making it a critical cellular response to ischemia.

“it has been reported that HIF-1α induction during reperfusion plays a role in preventing inappropriate repair following renal I/R (Conde et al., 2012), making it a critical cellular response to ischemia.”

• cites Conde et al., 2012 sourcePartly supported

  The Discussion (page not available in our copy) says reperfusion-induced HIF-1α is crucial for proximal tubule cell survival and recovery after renal I/R. The Results also report greater tubular damage when HIF-1α is inhibited. These passages support its role in repair, but do not specifically establish that it prevents inappropriate repair. (LLM, conf=0.84)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

At low concentrations (nanomolar range), CDDO protects cells and tissues from oxidative stress by enhancing Nrf2 transcriptional activity.

“At low concentrations (in the nanomolar range), CDDO protects cells and tissues from oxidative stress by enhancing the transcriptional activity of Nrf2 (Borella et al., 2019).”

• cites Borella et al., 2019 sourceSupported

Probably not a substantial claim: may not pass S3 (load-bearing).

At concentrations exceeding those required to activate the Nrf2 pathway (100 nM or higher), CDDO can regulate differentiation of various cell types.

“Furthermore, at concentrations exceeding those required to activate the Nrf2 pathway (100 nM or higher), it can regulate the differentiation of various cell types, including tumor cell lines and primary cultured cells (Borella et al., 2019).”

• cites Borella et al., 2019 sourceSupported

May combine two claims.

Drug responses varied across platforms, with CDDO exhibiting distinct efficacy profiles depending on the severity of oxygen limitation.

“drug responses varied across platforms, with CDDO exhibiting distinct efficacy profiles depending on the severity of oxygen limitation”

May combine two claims.

In all culture systems, decreasing the oxygen level set in the incubator reduced the oxygen concentration at the cell surface, but the extent of this reduction varied substantially among the platforms.

“In all culture systems, decreasing the oxygen level set in the incubator reduced the oxygen concentration at the cell surface; however, the extent of this reduction varied substantially among the platforms.”

• AssumptionRests on an assumption: The FEM model accurately predicts oxygen concentrations in the culture systems.

May combine two claims.

Under control (in-air, perfusion) conditions, both PDMS and PET chips maintained a confluent monolayer with no apparent morphological differences.

“Under control (in-air, perfusion) conditions, both PDMS and PET chips maintained a confluent monolayer with no apparent morphological differences (Figure 3B).”

May combine two claims.

Under static conditions (in-air, without medium perfusion) in microfluidic chips, the PDMS chip maintained sufficient oxygen levels even without perfusion, whereas the PET chip depleted oxygen within the channel.

“In the PDMS chip, sufficient oxygen levels were maintained even without perfusion, whereas in the PET chip, oxygen was depleted within the channel under static conditions (Supplementary Figure S4).”

• AssumptionRests on an assumption: The FEM model accurately predicts oxygen concentrations in the culture systems.

May combine two claims.

Under control (in-air) conditions, the OCR in microfluidic chips was comparable to the basal OCR, whereas in the insert, it was reduced to approximately half.

“Under control (in-air) conditions, the OCR in microfluidic chips was comparable to the basal OCR, whereas in the insert, it was reduced to approximately half.”

• AssumptionRests on an assumption: The FEM model accurately predicts oxygen concentrations in the culture systems.

May combine two claims.

GLUT1 and VEGFA exhibited expression patterns similar to HIF1A, and their upregulation was reversed after the reperfusion period following both the 5% and 1% O2 conditions.

“These two genes exhibit expression patterns similar to HIF1A, and their upregulation was reversed after the reperfusion period following both the 5% and 1% O2 conditions.”

May combine two claims.

Compared with the PET chip, the insert exhibited milder injury, indicating less severe oxygen limitation.

“Compared with the PET chip, the insert exhibited milder injury, indicating less severe oxygen limitation.”

May combine two claims.

In the PET chip, after the reperfusion period, cell detachment became evident even at 5% O2 and further expanded under 1% O2 conditions.

“After the reperfusion period, cell detachment became evident even at 5% O2 and further expanded under 1% O2 conditions (Figure 3B).”

May combine two claims.

In the PDMS chip, no morphological changes were observed even after 24 h of low-oxygen environments at 5% and 1% O2, and the monolayer remained intact after reperfusion.

“In the PDMS chip, no morphological changes were observed even after 24 h of low-oxygen environments at 5% and 1% O2, and the monolayer remained intact after reperfusion.”

May combine two claims.

In the cell viability assay, cell viability was slightly lower at 5% O2 than at ambient conditions, but it dropped sharply at 1% O2.

“In the cell viability assay, cell viability was slightly lower at 5% O2 than at ambient conditions, but it dropped sharply at 1% O2 (Figure 3C).”

May combine two claims.

KIM-1 expression was upregulated in the 1% O2 condition group after the ischemia period compared to the in-air condition group, and this upregulation was not reversed even after the reperfusion period.

“In contrast, KIM-1 expression was upregulated in the 1% O2 condition group after the ischemia period compared to the in-air condition group (Ctrl), and this upregulation was not reversed even after the reperfusion period.”

May combine two claims.

In the PET chip, a confluent monolayer was maintained after a low-oxygen environment at 5% O2, but significant cell detachment was observed at 1% O2.

“While a confluent monolayer was maintained after a low-oxygen environment at 5% O2, significant cell detachment was observed at 1% O2 (Figure 3B).”

May combine two claims.

Despite identical nominal oxygen conditions, only the PET chip reproduced ischemia-like injury, whereas the PDMS chip failed to induce detectable damage.

“Importantly, despite identical nominal oxygen conditions, only the PET chip reproduced ischemia-like injury, whereas the PDMS chip failed to induce detectable damage.”

May combine two claims.

At higher concentrations, cell viability decreased significantly at 100 μM in the culture insert and at concentrations exceeding 10 μM in the PET chip.

“However, at higher concentrations, cell viability decreased significantly at 100 µM in the culture insert and at concentrations exceeding 10 µM in the PET chip.”

May combine two claims.

In the insert, administration of CDDO showed a dose-dependent increase in cell viability up to approximately 100 nM, and at 100 nM, cell viability was significantly improved compared with the negative control (1% O2 I/R, No CDDO) group.

“In this study, administration of CDDO showed a dose-dependent increase in cell viability up to approximately 100 nM in the insert, and at 100 nM, cell viability was significantly improved compared with the negative control (1% O2 I/R, No CDDO) group (Figure 4A).”

May combine two claims.

Although CDDO exhibited both protective effects at low concentrations and cytotoxic effects at higher concentrations in both systems, the effective concentration range differed between the insert and the PET chip.

“Although CDDO exhibited both protective effects at low concentrations and cytotoxic effects at higher concentrations in both systems, the effective concentration range differed between the insert and the PET chip.”

May combine two claims.

The PET chip and the insert under reduced oxygen conditions generated strongly oxygen-deprived environments, whereas the PDMS chip exhibited a distinct oxygen transport profile characterized by relatively maintained oxygen availability and OCR despite the same nominal incubator oxygen settings.

“our analysis indicates that the PET chip and the insert under reduced oxygen conditions generated strongly oxygen-deprived environments, whereas the PDMS chip exhibited a distinct oxygen transport profile characterized by relatively maintained oxygen availability and OCR despite the same nominal incubator oxygen settings.”

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

In vitro studies on human RPTECs show that hypoxia-reoxygenation perturbs the intra- and extracellular metabolome and modulates transporter transcription within hours of injury.

“In vitro studies on human RPTECs further show that hypoxia–reoxygenation perturbs the intra- and extracellular metabolome and modulates transporter transcription within hours of injury”

• cites Faucher et al., 2023 sourceNot checked — no full text of the source

Classified as probably not a substantial claim.

Renal ischemia-reperfusion injury is one of the primary mechanisms underlying acute kidney injury.

“Renal ischemia-reperfusion (I/R) injury is one of the primary mechanisms underlying acute kidney injury (AKI)”

• cites Rewa and Bagshaw, 2014 sourceNot checked — no full text of the source
• cites Ronco et al., 2019 sourceNot checked — no full text of the source

Classified as probably not a substantial claim.

In vitro systems allow precise control of conditions such as oxygen levels and medium perfusion.

“in vitro systems allow precise control of conditions such as oxygen levels and medium perfusion”

• cites Russ et al., 2007 sourceNot checked — no full text of the source

Probably not a substantial claim: may not pass S3 (load-bearing).

Each sample was tested in at least two technical replicates.

“Each sample was tested in at least two technical replicates.”

Classified as probably not a substantial claim. May combine two claims.

Cell viability was evaluated by both qualitative microscopic observation and quantitative analysis using a Cell Counting Kit-8.

“Cell viability was evaluated by both qualitative microscopic observation and quantitative analysis using a Cell Counting Kit-8 (CK04, Dojindo, Kumamoto, Japan).”

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

Gene expression levels normalized to HPRT1 were used as a reference, and the calculated fold difference was compared with those in the in-air cell control.

“Gene expression levels normalized to HPRT1 were used as a reference, and the calculated fold difference was compared with those in the in-air cell control.”

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

The peristaltic pump's flow rate reliability was verified and falls within the manufacturer's guaranteed tolerance range of ±10%.

“We previously conducted experimental tests to verify the reliability of this pump’s flow rate and confirmed that it falls within the manufacturer’s guaranteed tolerance range of ±10%.”

Classified as probably not a substantial claim.

The use of the same PET membrane in both the chips and the insert allows the cellular substrate composition to be matched between the two platforms.

“The use of the same PET membrane in both the chips and the insert allows the cellular substrate composition to be matched between the two platforms; the difference between the two systems is therefore the surrounding material (chips vs. inserts) and the medium-handling regime (perfusion vs. static).”

Probably not a substantial claim: may not pass S3 (load-bearing).

High-throughput MPS studies have shown that the combination of low O2 conditions and perfusion stimulation is important for reproducing I/R-associated injury.

“high-throughput MPS studies have shown that the combination of low O2 conditions and perfusion stimulation is important for reproducing I/R-associated injury”

• cites Shaughnessey et al., 2024 sourceNot checked — no full text of the source

Classified as probably not a substantial claim.

The PDMS microfluidic chip was fabricated with the same geometry as the PET chip.

“A PDMS microfluidic chip with the same geometry as the PET chip was also fabricated (Figure 1B).”

May combine two claims.

The difference between the two systems (chips vs. inserts) is the surrounding material and the medium-handling regime (perfusion vs. static).

“the difference between the two systems is therefore the surrounding material (chips vs. inserts) and the medium-handling regime (perfusion vs. static).”

May combine two claims.

Oxygen transport is governed not only by incubator oxygen settings but also by material-dependent gas permeability and perfusion conditions.

“Taken together, these results suggest that oxygen transport is governed not only by incubator oxygen settings but also by material-dependent gas permeability and perfusion conditions.”

• AssumptionRests on an assumption: The FEM model accurately predicts oxygen concentrations in the culture systems.

May combine two claims.

The oxygen gradient in the insert is attributed to oxygen transport from the basal chamber through the microporous membrane, resulting in non-uniform oxygen distribution across the culture region.

“This gradient is attributed to oxygen transport from the basal chamber through the microporous membrane, resulting in non-uniform oxygen distribution across the culture region (Supplementary Figure S5).”

• AssumptionRests on an assumption: The FEM model accurately predicts oxygen concentrations in the culture systems.

May combine two claims.

Oxygen supply in PDMS is strongly influenced by diffusion through the material, whereas in the PET chip, oxygen availability is more dependent on medium perfusion.

“These results indicate that oxygen supply in PDMS is strongly influenced by diffusion through the material, whereas in the PET chip, oxygen availability is more dependent on medium perfusion.”

• AssumptionRests on an assumption: The FEM model accurately predicts oxygen concentrations in the culture systems.

May combine two claims.

The sensitivity analysis supports the robustness of the simulation model within the range of parameters examined and indicates that the main conclusions are not highly sensitive to plausible variations in OCR and Km.

“These results support the robustness of the simulation model within the range of parameters examined and indicate that the main conclusions are not highly sensitive to plausible variations in OCR and K m .”

• AssumptionRests on an assumption: The FEM model accurately predicts oxygen concentrations in the culture systems.

May combine two claims.

The high gas permeability of PDMS attenuates the establishment of severe oxygen consumption-limited conditions, whereas the PET chip and insert allow substantial oxygen limitation.

“In particular, the high gas permeability of PDMS attenuates the establishment of severe oxygen consumption-limited conditions, whereas the PET chip and insert allow substantial oxygen limitation.”

• AssumptionRests on an assumption: The FEM model accurately predicts oxygen concentrations in the culture systems.

Probably not a substantial claim: may not pass S3 (load-bearing).

The reduced HIF1A expression in the 1% O2 group may be because cellular damage was more severe under 1% O2, potentially leading to reduced HIF1A transcriptional activity compared with 5% O2.

“This may be because cellular damage was more severe under 1% O2, potentially leading to reduced HIF1A transcriptional activity compared with 5% O2.”

May combine two claims.

The PET chip exhibited ischemia-like injury, indicating that oxygen supply was insufficient to meet cellular demand.

“In contrast, the PET chip exhibited ischemia-like injury, indicating that oxygen supply was insufficient to meet cellular demand.”

May combine two claims.

The difference in injury between insert and PET chip likely arises from diffusion-driven oxygen supply from the medium and surrounding air in the insert system, whereas the PET chip restricts oxygen transport, resulting in a more pronounced oxygen deficit and stronger cellular injury.

“The difference likely arises from diffusion-driven oxygen supply from the medium and the surrounding air in the insert system, whereas the PET chip restricts oxygen transport, resulting in a more pronounced oxygen deficit and, consequently, stronger cellular injury.”

May combine two claims.

Although conventional cell culture insert systems can reproduce responses to low-oxygen concentrations, PET-based microfluidic systems enable the development of a more severe and controllable ischemic environment.

“These results suggest that although conventional cell culture insert systems can reproduce responses to low-oxygen concentrations, PET-based microfluidic systems enable the development of a more severe and controllable ischemic environment.”

Probably not a substantial claim: may not pass S3 (load-bearing).

Gene expression analysis could not be performed in the PET chip due to poor RNA harvest.

“although gene expression analysis could not be performed due to poor RNA harvest”

Probably not a substantial claim: may not pass S3 (load-bearing).

CDDO has been shown to be effective in animal models of AKI and renal I/R by potently inhibiting de novo synthesis of inflammatory enzymes such as iNOS and COX-2.

“It has also been shown to be effective in animal models of AKI and renal I/R by potently inhibiting the de novo synthesis of inflammatory enzymes such as inducible nitric oxide synthase and inducible cyclooxygenase-2 (Honda et al., 2000).”

• cites Honda et al., 2000 sourceNot checked — no full text of the source

Probably not a substantial claim: may not pass S3 (load-bearing).

The HIF-1α-VEGFA signaling pathway has been implicated in I/R injury in other organ contexts.

“The HIF-1α–VEGFA signaling pathway has been implicated in I/R injury in other organ contexts (Ni et al., 2022)”

• cites Ni et al., 2022Not matched

  Couldn’t be matched to a paper in Crossref, so it can’t be checked.

Probably not a substantial claim: may not pass S3 (load-bearing).

The slight decrease in HIF1A in the 1% O2 group is thought to be due to this cellular response.

“The slight decrease in HIF1A in the 1% O2 group is thought to be due to this cellular response.”

Probably not a substantial claim: may not pass S2 (checkable).

Based on the interpretation that 1% O2 corresponds to chronic hypoxia and 5% O2 to intermittent hypoxia, the results of this study are deemed reasonable.

“Based on the interpretation that 1% O2 corresponds to chronic hypoxia and 5% O2 to intermittent hypoxia, the results of this study are deemed reasonable.”

• AssumptionThe authors state this as an assumption: 1% O2 corresponds to chronic hypoxia and 5% O2 to intermittent hypoxia.

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

The renoprotective effects of CDDO are exerted by inducing increased expression of Nrf2, NQO1, and HO-1 in the kidneys, downregulating Keap1, activating Nrf2 signaling, and increasing downstream target genes.

“The renoprotective effects of CDDO are exerted by inducing increased expression of Nrf2, NQO1, and HO-1 in the kidneys, downregulating Kelch-like ECH-associated protein 1 (Keap1) expression, activating the Nrf2 signaling pathway, and increasing the expression of downstream target genes (Wu et al., 2014).”

• cites Wu et al., 2014Not matched

  Couldn’t be matched to a paper in Crossref, so it can’t be checked.

Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

There is a theoretical possibility that the sustained expression of hTERT may attenuate stress-induced aging responses.

“Additionally, there is a theoretical possibility that the sustained expression of hTERT may attenuate stress-induced aging responses.”

Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

The complexity of perfusion systems, including tubing and pump configurations, may affect usability and reproducibility.

“Second, the complexity of perfusion systems, including tubing and pump configurations, may affect usability and reproducibility.”

May combine two claims.

The difference in effective concentration range can be attributed to the severity of oxygen limitation, as the PET chip exhibits a more pronounced oxygen deficit, leading to greater baseline cellular injury and reduced sensitivity to protective effects.

“This difference can be attributed to the severity of oxygen limitation, as the PET chip exhibits a more pronounced oxygen deficit, leading to greater baseline cellular injury and, consequently, reduced sensitivity to protective effects.”

May combine two claims.

Oxygen transport is a critical determinant not only of disease model fidelity but also of drug response, emphasizing the necessity of oxygen-controlled platforms for reliable in vitro pharmacological testing.

“These results highlight that oxygen transport is a critical determinant not only of disease model fidelity but also of drug response, emphasizing the necessity of oxygen-controlled platforms for reliable in vitro pharmacological testing.”

Probably not a substantial claim: may not pass S3 (load-bearing).

At high concentrations (approximately 1 to 10 μM), CDDO activates extrinsic apoptosis.

“On the other hand, at high concentrations (ranging from approximately 1 to 10 μM, depending on the molecular or cellular model), CDDO activates extrinsic apoptosis (Ito et al., 2001).”

• cites Ito et al., 2001 sourceNot checked — no full text of the source

May combine two claims.

In drug testing with CDDO in a renal I/R model, the previously reported cytoprotective effects at low concentrations and cell death and damage at high concentrations were generally reproduced, demonstrating the utility of this model for drug testing.

“In drug testing with CDDO in a renal I/R model, the previously reported cytoprotective effects at low concentrations and cell death and damage at high concentrations were generally reproduced, demonstrating the utility of this model for drug testing.”

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

The RPTEC/TERT1 cells used in this study are immortalized, and their mitochondrial metabolic characteristics may differ slightly from those of primary cells.

“Finally, because the RPTEC/TERT1 cells used in this study are immortalized, their mitochondrial metabolic characteristics may differ slightly from those of primary cells.”

• AssumptionRests on an assumption: The RPTEC/TERT1 cells used in this study are immortalized.

May combine two claims.

Even under identical nominal oxygen settings (1% O2), material-dependent differences in oxygen supply result in distinct cellular conditions and consequently alter the dose-response of CDDO.

“Importantly, these findings indicate that, even under identical nominal oxygen settings (1% O2), material-dependent differences in oxygen supply result in distinct cellular conditions and consequently alter the dose-response of CDDO.”

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

The present study primarily focused on oxygen transport and cell viability, and only a limited set of gene expression markers was analyzed.

“In addition, the present study primarily focused on oxygen transport and cell viability, and only a limited set of gene expression markers was analyzed.”

Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

Microfluidic chips have lower throughput than conventional insert-based in vitro experimental models, limiting experimental scalability.

“First, microfluidic chips have lower throughput than conventional insert-based in vitro experimental models, limiting experimental scalability.”

May combine two claims.

PDMS chips did not reproduce ischemia-like cellular injury under the present conditions due to their high gas permeability, whereas PET chips enable robust, controllable I/R-associated cellular responses by limiting oxygen supply at the cellular level.

“our results suggest that PDMS chips did not reproduce ischemia-like cellular injury under the present conditions due to their high gas permeability, whereas PET chips enable robust, controllable I/R-associated cellular responses by limiting oxygen supply at the cellular level.”

• AssumptionRests on an assumption: PDMS chips have high gas permeability.

Probably not a substantial claim: may not pass S3 (load-bearing).

Pharmacological evaluation with CDDO was performed at a single oxygen-deprivation level (1% O2).

“Fourth, pharmacological evaluation with CDDO was performed at a single oxygen-deprivation level (1% O2).”

May combine two claims.

Even under identical nominal oxygen conditions, substantial differences in oxygen availability arise from material properties and culture configurations, leading to markedly different cellular phenotypes.

“Even under identical nominal oxygen conditions, substantial differences in oxygen availability arise from material properties and culture configurations, leading to markedly different cellular phenotypes.”